Physician

Carl Ray Dettwiler, MD

According to 2025 Medicare claims, Carl Dettwiler, MD (NPI: 1285623819) practices gastroenterology in the Lewiston, ID-WA market, with the plurality of this provider's patient population coming from Nez Perce, ID. This provider's primary affiliated billing organization is CLEARWATER GASTROENTEROLOGY (NPI: 1518205715; TIN: 46-1704768) and primary practice location at 83501-5709. Dettwiler is affiliated with the Kootenai Accountable Care, LLC (ACO ID: A3621), Caravan Collaborative Pathways (ACO ID: A4604), Caravan Health ACO 50 LLC (ACO ID: A5160), and Collaborative ACO 30, LLC (ACO ID: A5483), participating under the MSSP model.

Dettwiler's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 636 traditional Medicare patients, billed 1,938 HCPCS/CPT codes, and received $125,981 in Medicare payments. The top billing code was 45385 (Removal of polyps or growths of large bowel using an endoscope with mechanical snare). Part D data shows 1,555 prescription claims across 459 beneficiaries totaling $560,846 in drug costs, led by Creon (Lipase/Protease/Amylase). 2019 DME data shows 44 claims. Open Payments data shows 4 records totaling $260. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $352,773 to $560,846. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	615	1,293	$144,364
2016	730	1,425	$144,482
2017	626	1,798	$152,247
2018	705	2,097	$139,571
2019	658	1,858	$124,542
2020	618	1,656	$108,437
2021	614	1,675	$115,180
2022	555	1,495	$104,953
2023	605	1,723	$113,295
2024	636	1,938	$125,981

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	261	1,000	$352,773
2016	338	1,051	$283,029
2017	340	1,114	$299,639
2018	366	1,199	$286,405
2019	386	1,458	$699,919
2020	398	1,819	$789,124
2021	353	1,596	$710,063
2022	372	1,417	$795,854
2023	388	1,315	$807,826
2024	459	1,555	$560,846

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	44	$18,397
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
45385	Removal of polyps or growths of large bowel using an endoscope with mechanical snare	267	269	$183
43248	Insertion of guide wire with dilation of esophagus using a flexible endoscope	128	167	$111
45380	Biopsy of large bowel using a flexible endoscope	139	139	$48
43239	Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope	213	223	$44
G0500	Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito	574	751	$3

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Creon	Lipase/Protease/Amylase	12	344	$22,877
Mesalamine	Mesalamine	20	780	$9,012
Budesonide Dr	Budesonide	43	1,379	$7,263
Sucralfate	Sucralfate	102	3,269	$5,106
Omeprazole	Omeprazole	643	26,608	$4,609

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	4	$260	Janssen Biotech, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Carl Ray Dettwiler, MD?

Tedicare shows public-source Medicare data for Carl Ray Dettwiler, MD (NPI 1285623819), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Carl Ray Dettwiler, MD have ACO affiliation data?

Carl Ray Dettwiler, MD is shown with ACO affiliation data for Kootenai Accountable Care, LLC (MSSP, ACO ID A3621), Caravan Collaborative Pathways (MSSP, ACO ID A4604), Caravan Health ACO 50 LLC (MSSP, ACO ID A5160), and Collaborative ACO 30, LLC (MSSP, ACO ID A5483).

What billing organization is linked to Carl Ray Dettwiler, MD?

Carl Ray Dettwiler, MD is linked to CLEARWATER GASTROENTEROLOGY (billing NPI 1518205715) in the available physician profile data.

Does Carl Ray Dettwiler, MD have Open Payments data?

Carl Ray Dettwiler, MD has 4 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.